US 10591471
Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
granted A61KA61K38/00A61K38/177
Quick answer
US patent 10591471 (Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation) held by The Regents of the University of California expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61K38/177, A61P, A61P29/00